Evaluation of biomarkers and surrogate endpoints in chronic disease /

"Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in ord...

Full description

Bibliographic Details

Corporate Author:	Institute of Medicine (U.S.). Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease
Other Authors:	Micheel, Christine, Ball, John, 1944-
Format:	Book
Language:	English
Published:	Washington, D.C. : National Academies Press, [2010]
Subjects:	Biochemical markers > Evaluation. Chronic diseases. Biomarkers. Chronic Disease. Evidence-Based Practice.